Cargando…
Decreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma
Recently, protocadherin 20 has been reported as a tumor suppressor gene in hepatocellular carcinoma (HCC); however, the prognostic value of protocadherin 20 in HCC remains unclear. Hence, the purpose of this study was to investigate the clinical and prognostic values of protocadherin 20 in HCC patie...
Autores principales: | Wu, Yanqin, Zheng, Shuhui, Yao, Jiayan, Li, Minrui, Yang, Guang, Zhang, Ning, Zhang, Shenghong, Zhong, Bihui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356860/ https://www.ncbi.nlm.nih.gov/pubmed/27935871 http://dx.doi.org/10.18632/oncotarget.13822 |
Ejemplares similares
-
Decrease of Fibulin-3 in Hepatocellular Carcinoma Indicates Poor Prognosis
por: Luo, Rongzhen, et al.
Publicado: (2013) -
Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6
por: Huang, Shanshan, et al.
Publicado: (2023) -
Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma
por: Wang, Ying, et al.
Publicado: (2015) -
Decreased Expression of TMEM173 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Bu, Yang, et al.
Publicado: (2016) -
Decreased expression of ApoF associates with poor prognosis in human hepatocellular carcinoma
por: Wang, Ya-Bin, et al.
Publicado: (2019)